Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2023-06-15 Director's Dealing
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
Director's Dealing 2023
Director's Dealing
2023-06-15 English
FY 2022 11-K
Annual Report Classification · 95% confidence The document is titled 'FORM 11-K' and is described as an annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022. It contains audited financial statements and supplemental schedules for the Boston Scientific Corporation 401(k) Retirement Savings Plan. The content includes detailed financial statements, notes, and an auditor's report, indicating it is a full financial report rather than a brief announcement or certification. Form 11-K is a specific annual report for employee stock purchase, savings, and similar plans, which is distinct from the company's main 10-K annual report but is still an official annual report filing. Therefore, the document fits best under the category of Annual Report (10-K) filings for employee benefit plans, which aligns with the 10-K category in the provided classification scheme.
2023-06-15 English
Regulatory Filings 2023
Regulatory Filings
2023-06-07 English
8-K
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content describes the mandatory conversion of preferred stock into common stock and the subsequent delisting and deregistration of the preferred stock from the NYSE. This is an announcement of a capital structure change and a delisting event. The document is relatively short (4325 characters) and serves as an official notification rather than a detailed financial report. Therefore, it fits best under the Delisting Announcement (DLST) category, as it specifically mentions the delisting of the preferred stock and related actions.
2023-06-06 English
Delisting Announcement 2023
Delisting Announcement
2023-06-01 English
SD 2022 CONFLICT MINERALS REPORT
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the fiscal year ended December 31, 2022. It references the Conflict Minerals Report as an exhibit and includes regulatory language typical of SEC specialized disclosure filings. The document length is 3702 characters, which is relatively short and primarily serves as a regulatory disclosure rather than a full financial or management report. This type of filing is specialized and does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory filing focused on compliance with SEC rules regarding conflict minerals disclosure, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous SEC filings that do not fit other categories.
2023-05-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.